...
首页> 外文期刊>BMC Nephrology >Outcomes, risk factors and health burden of contrast-induced acute kidney injury: an observational study of one million hospitalizations with image-guided cardiovascular procedures
【24h】

Outcomes, risk factors and health burden of contrast-induced acute kidney injury: an observational study of one million hospitalizations with image-guided cardiovascular procedures

机译:对比剂诱发的急性肾损伤的结果,危险因素和健康负担:以图像为指导的心血管手术治疗一百万住院患者的观察性研究

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Background Despite the use of low-osmolar contrast media that have significantly reduced the occurrence of severe adverse reactions, contrast-induced (CI) acute kidney injury (AKI) remains the third cause of AKI in hospitals. We sought to estimate the frequency of CI-AKI among hospitalized patients undergoing image-guided cardiovascular procedures, to quantify the effect of risk factors on the development of this complication and to assess relative organizational and economic burden in healthcare. Methods A retrospective cross-sectional population-based study using the extensive French hospital discharge database (PMSI) was carried out. Hospitalizations with image-guided cardiovascular procedures using a contrast media were identified in adults over a 2-year period (2012–2013). Suspected CI-AKI was defined as the presence, during hospitalization, of a diagnostic code of AKI (International Classification of Diseases, 10th revision [ICD-10] codes: N141, 142, N144, N990, N17, N19 or R392) or a code of renal replacement therapy procedure (Classification Commune des Actes Médicaux [CCAM] codes: JVJB001, JVJF002-005 and JVJF008) as creatinine criteria were not available. Results During 1,047,329 hospitalizations studied, 32,308 suspected CI-AKI were observed, yielding a frequency of 3.1?%. By multivariate analysis, factors that significantly increased the risk of suspected CI-AKI included cardiogenic shock (odds ratio [OR]?=?20.5, 95?% confidence interval [95?% CI] [18.7; 22.5]), acute heart failure (OR?=?2.5, 95?% CI [2.4; 2.6]) and chronic kidney disease (OR?=?2.3, 95?% CI [2.2; 2.3]. Renal replacement therapy was initiated during 6,335 (0.6?%) hospitalizations. The mean length of stay and cost of hospitalizations associated with suspected CI-AKI was higher than in hospitalizations without suspected CI-AKI (20.5 vs 4.7 days, p Conclusions This is the first large-scale population-based study to estimate frequency and health burden of suspected CI-AKI occurring after image-guided cardiovascular procedures, and the first available data in a French population. We showed that this iatrogenic complication remains of high concern despite prevention efforts and contrast media product improvement. From our results, suspected CI-AKI is associated with particularly high mortality, significantly extends hospitalizations, and leads to additional costs reaching a total of €200M per year.
机译:背景技术尽管使用了低渗透压造影剂,该造影剂已大大减少了严重不良反应的发生,但造影剂诱发(CI)的急性肾损伤(AKI)仍然是医院中AKI的第三大原因。我们试图估计接受影像引导的心血管手术的住院患者中CI-AKI的发生频率,以量化风险因素对这种并发症发展的影响,并评估医疗保健方面的相对组织和经济负担。方法使用广泛的法国医院出院数据库(PMSI)进行基于人群的回顾性研究。在2年内(2012年至2013年),在成年人中确定了使用造影剂通过影像引导的心血管手术的住院治疗。疑似CI-AKI定义为住院期间存在AKI的诊断代码(国际疾病分类,第10版[ICD-10]代码:N141、142,N144,N990,N17,N19或R392)或由于尚无肌酐标准,因此没有肾脏替代治疗程序的代码(医学分类标准[CCAM]代码:JVJB001,JVJF002-005和JVJF008)。结果在所研究的1,047,329例住院中,观察到32,308例可疑CI-AKI,发生率为3.1%。通过多变量分析,显着增加可疑CI-AKI风险的因素包括心源性休克(赔率[OR]?=?20.5、95 %%置信区间[95 %% CI] [18.7; 22.5]),急性心力衰竭(OR?=?2.5,95%CI [2.4; 2.6])和慢性肾脏病(OR?=?2.3,95%CI [2.2; 2.3]。肾脏替代治疗始于6,335(0.6%)与可疑CI-AKI相关的平均住院时间和住院费用均高于无可疑CI-AKI的住院患者(20.5 vs 4.7天,p)结论这是首项基于人群的大规模研究,旨在估计发生频率和住院时间。影像引导的心血管手术后发生可疑CI-AKI的健康负担,以及法国人群的首次可用数据显示,尽管采取了预防措施和造影剂产品有所改善,但这种医源性并发症仍然令人高度关注。 -AKI与特别高的死亡率有关,大大延长了住院时间,并导致每年总计花费2亿欧元的额外费用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号